Xenetic Biosciences Inc.
XBIO | NASDAQ
$2.52
-$0.47 (-15.72%)
Sep 22, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.37 | -1.55 | -1.27 | -0.63 | -2.39 | -1.20 |
PEG Ratio | 0.04 | 0.30 | 0.03 | 0.04 | 0.04 | 0.02 |
PS Ratio | 1.24 | 2.46 | 2.08 | 2.38 | 11.42 | 29.84 |
PB Ratio | 0.50 | 1.02 | 0.54 | 0.30 | 0.72 | 1.07 |
P/FCF Ratio | -1.61 | -2.18 | -1.28 | -0.79 | -2.80 | -3.06 |
P/OCF Ratio | -1.61 | -2.18 | -1.28 | -0.87 | -2.80 | -3.06 |
OCF/S Ratio | -76.83 | -112.69 | -161.98 | -272.23 | -408.21 | -976.60 |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | 0 | 0.01 |
Quick Ratio | 8.32 | 7.37 | 11.84 | 12.72 | 13.18 | 13.20 |
Current Ratio | 8.32 | 7.37 | 11.84 | 12.72 | 13.18 | 13.20 |
Asset Turnover | 0.36 | 0.36 | 0.24 | 0.12 | 0.06 | 0.03 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -36.25% | -65.93% | -42.21% | -48.01% | -30.69% | -89.18% |
Return on Assets | -32.05% | -57.38% | -38.99% | -44.51% | -28.49% | -82.65% |
Return on Invested Capital | -38.33% | -69.99% | -46.10% | -49.23% | -31.20% | -89.53% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 100% | 100% | 100% |
Net Profit Margin | -90.07% | -158.39% | -162.78% | -383.87% | -486.36% | -2.49K% |
Pretax Profit Margin | -90.07% | -158.39% | -162.78% | -383.87% | -486.36% | -3.16K% |
Operating Profit Margin | -95.23% | -168.16% | -177.78% | -393.57% | -495.12% | -3.19K% |
FCF Margin | -76.83% | -112.69% | -161.98% | -301.52% | -408.21% | -976.60% |
EBITDA Margin | -90.07% | -152.26% | -162.78% | -382.28% | -483.31% | -1.07K% |
Add to Watchlist
Select watchlists to add or remove XBIO